Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | FPR1 | P21462 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15592505 | 1.00 | TP53 (0.50) | TP53SLC7A5TSHRFPR1FPR2 | |
| SCHEMBL9720978 | 0.87 | TP53 (0.56) | TP53SLC7A5TSHRRNPEPCYP1A2 | |
| SCHEMBL16438180 | 0.83 | TP53 (0.50) | TP53SLC7A5TSHRFPR1FPR2 | |
| SCHEMBL659817 | 0.83 | TP53 (0.50) | TP53SLC7A5TSHRFPR1FPR2 | |
| SCHEMBL66413 | 0.83 | TP53 (0.50) | TP53SLC7A5TSHRFPR1FPR2 | |
| SCHEMBL28263618 | 0.81 | TP53 (0.50) | TP53SLC7A5TSHRFPR1FPR2 | |
| Water SCHEMBL8870694 | 0.80 | TP53 (0.47) | TP53SLC7A5TSHRFPR1FPR2 | |
| SCHEMBL3760910 | 0.79 | TSHR (0.50) | TP53SLC7A5TSHRFPR1FPR2 | |
| SCHEMBL9722956 | 0.79 | TSHR (0.50) | TP53SLC7A5TSHR | |
| SCHEMBL19585105 | 0.79 | TSHR (0.50) | TP53SLC7A5TSHRFPR1FPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1337146-B1 | AEROSOL INSECT REPELLENT COMPOSITION HAVING LOW VOC CONTENT AND METHOD OF APPLYING SAME TO THE SKIN | AVON PROD INC (US) | 2006-02-08 | — | — | EP | claimed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-9145425-B2 | Cephem compound having catechol group | SHIONOGI & CO., LTD. (JP) | 2015-09-29 | — | — | US | disclosed |
| US-9115083-B2 | Compounds from Antrodia cinnamomea and use thereof | SIMPSON BIOTECH CO., LTD. (TW) | 2015-08-25 | — | — | US | disclosed |
| US-8883773-B2 | Cephem compound having pseudo-catechol group | SHIONOGI & CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-20140179753-A1 | COMPOUNDS FROM ANTRODIA CINNAMOMEA AND USE THEREOF | SIMPSON BIOTECH CO., LTD. (TW) | 2014-06-26 | — | — | US | disclosed |
| US-8703968-B2 | Compounds from Antrodia cinnamomea and use thereof | SIMPSON BIOTECH CO., LTD. (TW) | 2014-04-22 | — | — | US | disclosed |
| US-20130225649-A1 | COMPOUNDS FROM ANTRODIA CINNAMOMEA AND USE THEREOF | SIMPSON BIOTECH CO., LTD. (TW) | 2013-08-29 | — | — | US | disclosed |
| US-20130102583-A1 | CEPHEM COMPOUND HAVING CATECHOL GROUP | SHIONOGI & CO., LTD. (JP) | 2013-04-25 | — | — | US | disclosed |
| US-20130079319-A1 | CEPHEM COMPOUND HAVING PSEUDO-CATECHOL GROUP | SHIONOGI & CO., LTD. (JP) | 2013-03-28 | — | — | US | disclosed |
| EP-2348833-A2 | LIQUID AQUEOUS CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2346322-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010040835-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010040834-A2 | LIQUID AQUEOUS CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079319-A1 | CEPHEM COMPOUND HAVING PSEUDO-CATECHOL GROUP | CENPE, CCNE2, CEP170 | TP53 2491/4885SLC7A5 65/4885TSHR 4026/4885 |
| US-20130225649-A1 | COMPOUNDS FROM ANTRODIA CINNAMOMEA AND USE THEREOF | HAVCR2, CYP51A1, NPC1 | TP53 1729/4885SLC7A5 3463/4885TSHR 4880/4885 |
| US-20130102583-A1 | CEPHEM COMPOUND HAVING CATECHOL GROUP | COMT, EZH1, SETD7 | TP53 1824/4885SLC7A5 33/4885TSHR 4191/4885 |
| US-20140179753-A1 | COMPOUNDS FROM ANTRODIA CINNAMOMEA AND USE THEREOF | HAVCR2, CYP51A1, NPC1 | TP53 1729/4885SLC7A5 3463/4885TSHR 4880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.